Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
LadRx Corp
LADX
Healthcare
Biotechnology
LadRx Corp is a biopharmaceutical research and development company specializing in oncology. The Company focuses on the discovery, research and clinical development of anti-cancer drug candidates that employ technologies that target chemotherapeutic drugs to solid tumors and reduce off-target toxicities. The Company’s linker activated drug release (LADR) technology platform consists of an...
organic backbone that is attached to a chemo toxic agent. The LADR backbone is to first target and deliver the chemo toxic agent to the tumor environment, and then to release the chemo toxic agent within the tumor. The LADR Technology offers the opportunity for multiple pipeline drugs. The LADR development efforts are focused on two classes of ultra-high potency albumin-binding drugs. These LADR-based drugs, LADRs 7, 8, 9, and 10, combine the proprietary LADR backbone with derivatives of the auristatin and maytansinoid drug classes.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCQB:LADX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Nov 04, 2013 6:54pm
CytRx Corp. (CYTR) Addressing Significant Medical Needs with
CytRx Corp. (CYTR) Addressing Significant Medical Needs with Four Key Initiatives on Deck CytRx is a biotech company focused on developing and commercializing the candidates in its oncology-focused
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Nov 01, 2013 4:32pm
CytRx Corp. (CYTR) Gets Positive Review in Seeking Alpha’s E
CytRx Corp. (CYTR) Gets Positive Review in Seeking Alpha’s Equity Stock Guru Article Oncological biopharm company CytRx today was featured in a Seeking Alpha article detailing the
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Oct 31, 2013 8:15pm
CytRX Corp. (CYTR) Reports Further Developments in Global Ph
CytRX Corp. (CYTR) Reports Further Developments in Global Phase 2b Trial CytRX Corp., a biopharmaceutical research and development company specializing in oncology, today released further clinical
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Oct 29, 2013 6:57pm
CytRx Corp. (CYTR) Reports Q3 2013 Financial Results and Cli
CytRx Corp. (CYTR) Reports Q3 2013 Financial Results and Clinical Update CytRx Corp. today announced its financial results and clinical update for the quarter ended September 30, 2013. “Our
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Oct 28, 2013 6:44pm
CytRx Corp. (CYTR) – CEO Steven A. Kriegsman at the Helm
CytRx Corp. (CYTR) – CEO Steven A. Kriegsman at the Helm Los Angeles-based CytRx Corporation is a biopharmaceutical research and development company specializing in oncology. The company&
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Oct 25, 2013 8:02pm
CytRx Corp. (CYTR) Continues to Build Oncology Portfolio, He
CytRx Corp. (CYTR) Continues to Build Oncology Portfolio, Headed by Lead Candidate Aldoxorubicin CytRx is a biopharmaceutical research and development company with a particular focus on expanding its
...more
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario